NCT05009953 2024-07-11
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2 Terminated
CSPC Ouyi Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
Helsinn Healthcare SA